Implementation of a standardized pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
The increasing cost of anticancer drugs is now being recognized as a global problem, and measures against drug wastage are among the most important cost containment strategies for anticancer drugs. When blood examination results or changes to a patient's condition necessitate dose reduction or discontinuation of anticancer drugs after their preparation, the compounded anticancer drugs are discarded. To reduce anticancer drug wastage after preparation, we developed a protocol that set the eligibility, start of treatment, dose reduction and discontinuation criteria for injectable anticancer drugs, and assessed the effect of pharmacists' checks of these criteria based on the present protocol prior to preparation of injectable anticancer drugs. Observations before and after introduction of the protocol were conducted at Gifu University Hospital. We recorded the number, type and cost of anticancer drugs discarded after preparation and the reason for discarding these drugs in our dedicated database. Checking the criteria for anticancer drug administration before preparation significantly reduced the rate at which anticancer drugs within a chemotherapy cycle were discarded after preparation compared with that prior to the protocol's introduction [0.367% (18/4,909) vs 0.032% (2/6,248), P<0.001]. Additionally, the total cost of anticancer drugs discarded after preparation was reduced from JPY 2,041,786 (USD 18,562) to JPY 398,414 (USD 3,622). Pharmacists' checks of the eligibility, start of treatment, dose reduction and discontinuation criteria for anticancer drugs based on the present protocol prior to preparation of injectable anticancer drugs was useful for reducing drug wastage after preparation.